Antibodies are among the most relevant biomolecular targets
for
diagnostic and clinical applications. In this Perspective, we provide
a critical overview of recent research efforts focused on the development
and characterization of devices, switches, and reactions based on
the use of synthetic antigen-conjugated DNA strands designed to be
responsive to specific antibodies. These systems can find applications
in sensing, drug-delivery, and antibody–antigen binding characterization.
The examples described here demonstrate how the programmability and
chemical versatility of synthetic nucleic acids can be used to create
innovative analytical tools and target-responsive systems with promising
potentials.